Related Experiment Videos

Direct in vivo measurement of targeted binding in a human tumor xenograft

D A Berk1, F Yuan, M Leunig

  • 1Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston 02114, USA.

Insights

This study introduces a novel method using fluorescence recovery after photobleaching to quantify in vivo receptor-ligand binding. The technique successfully measured antibody affinity and antigen density in human tumors, offering new insights into biological interactions.

Area of Science:

  • Biophysics
  • Molecular Biology
  • Oncology

Background:

  • Quantifying molecular binding in living tissues is challenging.
  • Receptor-ligand interactions are fundamental to biological processes.

Purpose of the Study:

  • To develop and validate a method for direct in vivo measurement of receptor-ligand binding.
  • To quantify the binding affinity of monoclonal antibodies (mAbs) to their target antigens in human tumor xenografts.

Main Methods:

  • Utilized fluorescence recovery after photobleaching (FRAP) to detect ligand immobilization due to receptor binding.
  • Applied the method to measure mAb affinity and estimate antigen density in vivo.

Main Results:

  • Demonstrated a saturable binding isotherm for mAb-antigen interactions in human tumor xenografts.
  • Estimated in vivo carcinoembryonic antigen density at 0.56 nmol/g (5.0 x 10^5 cells) and an association constant (Ka) <= 4 x 10^7 M^-1.

Conclusions:

  • Fluorescence recovery after photobleaching is a viable technique for in vivo quantification of receptor-ligand binding.
  • The method has broad applicability for studying cell signaling, targeted drug delivery, and gene therapy in vivo.

Related Concept Videos